University of Houston
The goal of this feasibility clinical trial is to learn whether a two-week program involving gentle stimulation of the vagus nerve at the ear (taVNS) is practical and acceptable for healthy young adults. The study will also evaluate whether collecting information about heart rate patterns and well-being is feasible during the program. If this study is feasible and acceptable, the research team will conduct a larger study to see if taVNS alone or in combination with listening to audio instructions is helpful for individuals in terms of mental and physical health.
Inclusion Criteria: 1. 18 years to 29 years old 2. fluent in English 3. non-pregnant female participants using effective contraception 4. participants with baseline Root Mean Square of Successive Differences (RMSSD, a measure of the variation in time between consecutive heartbeats) within 1 SD below the mean identified by Tegenge et al (2020): Women Men Age Bin Mean Mean- 1SD Mean Mean- 1SD 15-19\* 73.8 23.3 70.8. 22 20-24 64.7 17.4 57.3 17.2 25-29 58.0 18 52.1 13.3 \*Only individuals \>18 years old are eligible, but the 15-19 age bin will be used for participants falling in this age range.…
This study will use the commercially available taVNS device from Parasym (referred to as Auricular Vagal Nerve Treatment (AVNT) device in research contexts and as Nuropod commercially in the United States), a noninvasive external ear stimulation device that delivers low-level electrical stimulation to the auricular branch of the vagus nerve. For those in the taVNS condition, mild electrical impulses at controlled low voltages using a biocompatible reusable electrode will be administered. Participants will come to the lab 5 days/week for 2 weeks (10 sessions) and receive 30 minutes of taVNS.
For those in the mindfulness meditation (MM) conditions, participants will be presented with an 10- to 15-minute MM audio recording designed to deliver mindfulness training from the Mindfulness Coach app developed by the Veteran Affairs' National Center for PTSD. MM will be delivered in the first 10-15 minutes of each 30-minute taVNS (or sham taVNS) session.
This study will use the commercially available taVNS device from Parasym (referred to as Auricular Vagal Nerve Treatment (AVNT) device in research contexts and as Nuropod commercially in the United States), a noninvasive external ear stimulation device that delivers low-level electrical stimulation to the auricular branch of the vagus nerve. For those in the sham taVNS condition, a biocompatible reusable electrode will be placed on participant's triages, but no electrical stimulation will be applied. Participants will come to the lab 5 days/week for 2 weeks (10 sessions) and receive 30 minutes of sham taVNS.
Arctuva estimate
Verify or correct the compensation shown for this listing.